Financial News
Biopharma company faces pressure to trim costs and maximize value for shareholders
May 22, 2021 at 07:54 AM EDT
Alkermes, a biopharmaceutical company, benefits from profitable drugs and royalties, but a “bloated cost structure” keeps it from being profitable.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
